The Cancer Research Institute International Symposia Series

The Institute's International Symposia Series, established in 1991, is considered by many as "the Davos of cancer immunology," where the world's scientific leaders in immunology and tumor immunology gather together to shape the future course of cancer research.

These annual meetings focus attention on progress in cancer vaccines and antibody-based therapies, the two central approaches of cancer immunology. Over the course of three days, researchers involved in the discovery and development of immune-based therapies for cancer share information, stimulating new ideas and collaborations that could benefit the development of experimental cancer immunotherapies.

Visit the CRI Symposium webpage